Dyne Accounts Payable vs Common Stock Shares Outstanding Analysis
DYN Stock | USD 26.00 0.05 0.19% |
Dyne TherapeuticsInc financial indicator trend analysis is much more than just examining Dyne TherapeuticsInc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dyne TherapeuticsInc is a good investment. Please check the relationship between Dyne TherapeuticsInc Accounts Payable and its Common Stock Shares Outstanding accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.
Accounts Payable vs Common Stock Shares Outstanding
Accounts Payable vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dyne TherapeuticsInc Accounts Payable account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have weak relationship.
The correlation between Dyne TherapeuticsInc's Accounts Payable and Common Stock Shares Outstanding is 0.37. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Dyne TherapeuticsInc, assuming nothing else is changed. The correlation between historical values of Dyne TherapeuticsInc's Accounts Payable and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Dyne TherapeuticsInc are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Accounts Payable i.e., Dyne TherapeuticsInc's Accounts Payable and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.37 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Accounts Payable
An accounting item on the balance sheet that represents Dyne TherapeuticsInc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Dyne TherapeuticsInc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Dyne TherapeuticsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dyne TherapeuticsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.As of the 10th of May 2024, Issuance Of Capital Stock is likely to grow to about 126.9 M, while Selling General Administrative is likely to drop about 29.8 K.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 1.1M | 1.7M | 1.7M | 997.5K | Research Development | 121.3M | 142.8M | 210.8M | 221.3M |
Dyne TherapeuticsInc fundamental ratios Correlations
Click cells to compare fundamentals
Dyne TherapeuticsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dyne TherapeuticsInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 16.4M | 353.3M | 425.7M | 306.3M | 165.1M | 156.8M | |
Short Long Term Debt Total | 8.4B | 3.4M | 32.6M | 30.5M | 27.4M | 26.0M | |
Other Current Liab | 1.1M | 7.5M | 20.8M | 18.2M | 23.4M | 22.3M | |
Total Current Liabilities | 2.4M | 11.0M | 28.7M | 28.1M | 51.1M | 48.5M | |
Total Stockholder Equity | 14.0M | 342.4M | 368.2M | 252.4M | 91.3M | 86.7M | |
Property Plant And Equipment Net | 1.5M | 1.9M | 41.0M | 38.4M | 33.4M | 31.7M | |
Net Debt | (14.6M) | (300.9M) | (168.2M) | (141.7M) | (94.2M) | (89.5M) | |
Accounts Payable | 1.3M | 3.4M | 4.0M | 5.3M | 22.9M | 21.8M | |
Cash | 14.6M | 300.9M | 200.8M | 172.1M | 121.6M | 115.5M | |
Non Current Assets Total | 1.7M | 8.0M | 43.3M | 50.3M | 35.7M | 33.9M | |
Non Currrent Assets Other | 191K | 3.8M | 2.3M | 9.6M | (1.0) | (0.95) | |
Cash And Short Term Investments | 14.6M | 345.3M | 376.6M | 256.0M | 123.1M | 116.9M | |
Common Stock Shares Outstanding | 45.4M | 14.4M | 50.9M | 52.0M | 59.7M | 56.7M | |
Liabilities And Stockholders Equity | 16.4M | 353.3M | 425.7M | 306.3M | 165.1M | 156.8M | |
Non Current Liabilities Total | 42K | 3.4M | 28.7M | 25.9M | 22.7M | 21.6M | |
Other Current Assets | 127K | 3.8M | 5.8M | 9.6M | 6.3M | 6.0M | |
Other Stockholder Equity | 6.4M | 421.6M | 596.9M | 649.5M | 723.8M | 687.6M | |
Total Liab | 2.4M | 11.0M | 57.5M | 54.0M | 73.8M | 70.1M | |
Property Plant And Equipment Gross | 1.5M | 1.9M | 42.9M | 42.0M | 38.7M | 36.7M | |
Total Current Assets | 14.8M | 345.3M | 382.4M | 256.0M | 129.4M | 122.9M | |
Accumulated Other Comprehensive Income | 0.0 | (27K) | (269K) | (571K) | (656.7K) | (689.5K) | |
Retained Earnings | (19.7M) | (79.2M) | (228.5M) | (396.6M) | (632.5M) | (664.1M) | |
Net Tangible Assets | (13.4M) | 342.4M | 368.2M | 252.4M | 290.2M | 207.8M | |
Net Invested Capital | (13.4M) | 342.4M | 368.2M | 252.4M | 91.3M | 86.7M | |
Net Working Capital | 12.4M | 338.1M | 353.7M | 237.5M | 78.3M | 74.4M | |
Property Plant Equipment | 1.5M | 1.9M | 41.0M | 38.4M | 44.2M | 46.4M |
Pair Trading with Dyne TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyne Stock
0.81 | A | Agilent Technologies Buyout Trend | PairCorr |
0.83 | ELEV | Elevation Oncology Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Dyne TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne TherapeuticsInc to buy it.
The correlation of Dyne TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.